7235 related articles for article (PubMed ID: 2809274)
21. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Papadopoulou MV; Ji M; Khan SH; Bloomer WD
Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
[TBL] [Abstract][Full Text] [Related]
22. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
Herman TS; Teicher BA; Cathcart KN; Kaufmann ME; Lee JB; Lee MH
Cancer Res; 1988 Sep; 48(18):5101-5. PubMed ID: 3409235
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
24. The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines.
Goss P; Parsons PG
Cancer Res; 1977 Jan; 37(1):152-6. PubMed ID: 830403
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
[TBL] [Abstract][Full Text] [Related]
26. The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis.
Nakao K; Otsuki Y; Akao Y; Ito Y; Marukawa O; Tachibana S; Kawakami M; Sasaki S
Med Electron Microsc; 2000; 33(1):44-50. PubMed ID: 11810457
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
28. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
29. Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin.
Debes A; Oerding M; Willers R; Göbel U; Wessalowski R
Anticancer Res; 2003; 23(4):3359-66. PubMed ID: 12926076
[TBL] [Abstract][Full Text] [Related]
30. Sensitization of nitrosourea-resistant Mer+ human tumor cells to N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea by mild (41 degrees C) hyperthermia.
Mulcahy RT; Gipp JJ; Tanner MA
Cancer Res; 1988 Mar; 48(5):1086-90. PubMed ID: 3342391
[TBL] [Abstract][Full Text] [Related]
31. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
32. [Cytotoxic effect of hyperthermia and nitrocaphane on malignant HEp-2 cells].
Li LG
Zhonghua Zhong Liu Za Zhi; 1989 Jan; 11(1):31-3. PubMed ID: 2776644
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells.
Chitnis M; Juvekar A; Adwankar M; Advani S
Anticancer Res; 1986; 6(4):749-51. PubMed ID: 3463243
[TBL] [Abstract][Full Text] [Related]
34. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
Frankfurt OS; Seckinger D; Sugarbaker EV
Anticancer Res; 1993; 13(4):947-52. PubMed ID: 8352564
[TBL] [Abstract][Full Text] [Related]
36. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
Lai SL; Hwang J; Perng RP; Whang-Peng J
Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
[TBL] [Abstract][Full Text] [Related]
37. Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.
Robins HI; D'Oleire F; Grosen E; Spriggs D
Anticancer Res; 1997; 17(4B):2891-4. PubMed ID: 9329556
[TBL] [Abstract][Full Text] [Related]
38. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
39. Clinical hyperthermia and chemotherapy.
Storm FK
Radiol Clin North Am; 1989 May; 27(3):621-7. PubMed ID: 2648463
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells.
Fujiwara K; Modest EJ; Welander CE; Wallen CA
Cancer Res; 1989 Nov; 49(22):6285-9. PubMed ID: 2804975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
